Vestcor Inc’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.7M | Buy |
21,514
+83
| +0.4% | +$10.4K | 0.08% | 270 |
|
|
2025
Q1 | $2.37M | Buy |
21,431
+1,565
| +8% | +$173K | 0.08% | 262 |
|
|
2024
Q4 | $2.71M | Sell |
19,866
-342
| -2% | -$46.7K | 0.09% | 232 |
|
|
2024
Q3 | $2.33M | Sell |
20,208
-4,884
| -19% | -$563K | 0.07% | 261 |
|
|
2024
Q2 | $3.45M | Hold |
25,092
| – | – | 0.12% | 195 |
|
|
2024
Q1 | $3.46M | Sell |
25,092
-258
| -1% | -$35.6K | 0.12% | 193 |
|
|
2023
Q4 | $3.34M | Buy |
25,350
+981
| +4% | +$129K | 0.11% | 188 |
|
|
2023
Q3 | $2.74M | Buy |
24,369
+7,128
| +41% | +$802K | 0.1% | 206 |
|
|
2023
Q2 | $1.63M | Buy |
17,241
+3,799
| +28% | +$358K | 0.06% | 319 |
|
|
2023
Q1 | $1.36M | Hold |
13,442
| – | – | 0.05% | 368 |
|
|
2022
Q4 | $1.61M | Buy |
13,442
+6,426
| +92% | +$768K | 0.06% | 348 |
|
|
2022
Q3 | $745K | Buy |
7,016
+4,800
| +217% | +$510K | 0.03% | 563 |
|
|
2022
Q2 | $216K | Buy |
2,216
+716
| +48% | +$69.8K | 0.01% | 893 |
|
|
2022
Q1 | $141K | Sell |
1,500
-1,896
| -56% | -$178K | ﹤0.01% | 1018 |
|
|
2021
Q4 | $289K | Sell |
3,396
-482
| -12% | -$41K | 0.01% | 761 |
|
|
2021
Q3 | $372K | Sell |
3,878
-178
| -4% | -$17.1K | 0.01% | 667 |
|
|
2021
Q2 | $395K | Buy |
4,056
+1,577
| +64% | +$154K | 0.01% | 681 |
|
|
2021
Q1 | $241K | Hold |
2,479
| – | – | 0.01% | 777 |
|
|
2020
Q4 | $238K | Hold |
2,479
| – | – | 0.01% | 704 |
|
|
2020
Q3 | $238K | Hold |
2,479
| – | – | 0.01% | 629 |
|
|
2020
Q2 | $302K | Buy |
+2,479
| New | +$302K | 0.02% | 515 |
|